Ledger.Open graph →
SEC Form D · filed December 26, 2018

ZETAGEN THERAPEUTICS, INC

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SYRACUSE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Peter B. Finn · Boston, MAExec · DirectorJoshua Resnick · Boston, MAExec · DirectorNikhil Thakur, Md · Andover, MAExec · DirectorDavid B. Tischler · Berkley, CAExec · DirectorHans Miller · Arlington, VAExec · DirectorRobert Poulin · Arlington, VAExec · DirectorDavid B. Tischler · Berkley, CAExec · DirectorAndrew Levin · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗